Differentiating the pathological subtypes of primary lung cancer for patients with brain metastases based on radiomics features from brain CT images

被引:14
|
作者
Zhang, Ji [1 ]
Jin, Juebin [1 ]
Ai, Yao [1 ]
Zhu, Kecheng [1 ]
Xiao, Chengjian [1 ]
Xie, Congying [1 ,2 ]
Jin, Xiance [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat & Med Oncol, Wenzhou 325000, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiat & Med Oncol, 109 West Xueyuan Rd, Wenzhou 325000, Peoples R China
基金
中国国家自然科学基金;
关键词
Brain tumors; Metastasis; Non-small-cell lung cancer; Adenocarcinoma; Squamous cell carcinoma; CELL CARCINOMA; DIAGNOSIS; GUIDELINES; SYSTEM;
D O I
10.1007/s00330-020-07183-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives It is of high clinical importance to identify the primary lesion and its pathological types for patients with brain metastases (BM). The purpose of this study is to investigate the feasibility and accuracy of differentiating the primary adenocarcinoma (AD) and squamous cell carcinoma (SCC) of non-small-cell lung cancer (NSCLC) for patients with BM based on radiomics from brain contrast-enhanced computer tomography (CECT) images. Methods A total of 144 BM patients (94 male, 50 female) were enrolled in this study with 102 with primary lung AD and 42 with SCC, respectively. Radiomics features from manually contoured tumors were extracted using python. Mann-WhitneyUtest and the least absolute shrinkage and selection operator (LASSO) logistic regression were applied to select relative radiomics features. Binary logistic regression and support vector machines (SVM) were applied to build models with radiomics features alone and with radiomics features plus age and sex. Results Fourteen features were selected from a total of 105 radiomics features for the final model building. The area under the curves (AUCs) and accuracy of SVM and binary logistic regression models were 0.765 vs. 0.769, 0.795 vs.0.828, and 0.716 vs. 0.726, 0.768 vs. 0.758, respectively, for models with radiomics features alone and models with radiomics features plus sex and age. Conclusions Brain CECT radiomics are promising in differentiating primary AD and SCC to achieve optimal therapeutic management in patients with BM from NSCLC.
引用
收藏
页码:1022 / 1028
页数:7
相关论文
共 50 条
  • [41] CT and MRI bimodal radiomics for predicting EGFR status in NSCLC patients with brain metastases: A multicenter study
    Ouyang, Zhiqiang
    Zhang, Guodong
    He, Shaonan
    Huang, Qiubo
    Zhang, Liren
    Duan, Xirui
    Zhang, Xuerong
    Liu, Yifan
    Ke, Tengfei
    Yang, Jun
    Ai, Conghui
    Lu, Yi
    Liao, Chengde
    EUROPEAN JOURNAL OF RADIOLOGY, 2025, 183
  • [42] Parotid metastases from primary lung cancer: Case series and systematic review of the features
    Wang, Rulan
    Wang, Ting
    Zhou, Qinghua
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [43] Patterns of Radiotherapy Utilization for Lung Cancer Patients with Brain Metastases: A Population-based Analysis
    Schlijper, Roel
    Fraser, Ian M.
    Regan, Jacqueline
    Lefresne, Shilo
    Ho, Cheryl
    Olson, Robert A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (09)
  • [44] CHEMOTHERAPY IN NON SMALL CELL LUNG CANCER PATIENTS WITH BRAIN METASTASES
    Sathyarathnam, Gokul
    Peedell, Clive
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1308 - S1309
  • [45] A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer
    Fan, Yun
    Huang, Zhiyu
    Fang, Luo
    Miao, Lulu
    Gong, Lei
    Yu, Haifeng
    Yang, Haiyan
    Lei, Tao
    Mao, Weimin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (03) : 517 - 523
  • [46] Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer
    Doherty, Mark K.
    Korpanty, Grzegorz J.
    Tomasini, Pascale
    Alizadeh, Moein
    Jao, Kevin
    Labbe, Catherine
    Mascaux, Celine M.
    Martin, Petra
    Kamel-Reid, Suzanne
    Tsao, Ming-Sound
    Pintilie, Melania
    Liu, Geoffrey
    Bradbury, Penelope A.
    Feld, Ronald
    Leighl, Natasha B.
    Chung, Caroline
    Shepherd, Frances A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 (02) : 195 - 202
  • [47] Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy
    Zeng, Yin-duo
    Liao, Hai
    Qin, Tao
    Zhang, Li
    Wei, Wei-dong
    Liang, Jian-zhong
    Xu, Fei
    Dinglin, Xiao-xiao
    Ma, Shu-xiang
    Chen, Li-kun
    ONCOTARGET, 2015, 6 (10) : 8366 - 8376
  • [48] Response to radiotherapy in brain metastases and survival of patients with non-small cell lung cancer
    Antoniou, D
    Kyprianou, K
    Stathopoulos, GP
    Skarleas, C
    Kolitsi, G
    Veslemes, M
    Dimitroulis, J
    Giamboudakis, P
    Marosis, K
    Armenaki, O
    Papageorgiou, C
    Katis, C
    ONCOLOGY REPORTS, 2005, 14 (03) : 733 - 736
  • [49] Aggressive Treatment of Primary Tumor in Patients With Non-Small-Cell Lung Cancer and Exclusively Brain Metastases
    Villarreal-Garza, Cynthia
    de la Mata, Dolores
    Zavala, Diego G.
    Macedo-Perez, Eleazar O.
    Arrieta, Oscar
    CLINICAL LUNG CANCER, 2013, 14 (01) : 6 - 13
  • [50] Enhancement of Radiosurgical Treatment Outcome Prediction Using MRI Radiomics in Patients with Non-Small Cell Lung Cancer Brain Metastases
    Liao, Chien-Yi
    Lee, Cheng-Chia
    Yang, Huai-Che
    Chen, Ching-Jen
    Chung, Wen-Yuh
    Wu, Hsiu-Mei
    Guo, Wan-Yuo
    Liu, Ren-Shyan
    Lu, Chia-Feng
    CANCERS, 2021, 13 (16)